RBR-6xwc26进行中（未招募）2 期
Efficacy and effectiveness of inhaled Ciclesonide in the treatment of acute Asthma attack: double-blind randomized clinical trial
niversidade Federal de São Paulo-Escola Paulista de Medicina0 个研究点开始时间: 2017年1月12日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
入选标准
- •Asthmatic patients aged greater than 13 years, with no upper limit and of both sexes, diagnosed with asthma according to the criteria of the GINA (Global Initiative for Asthma), moderate or severe asthma,that is, with lower FEV1 50 %.
排除标准
- •Excluded patients with a body temperature greater than or equal 37,8º; smoking; pregnant women; patients in psychiatric treatment or with a history of heart disease, liver, kidney or other diseases that prevent the use of corticosteroids; patients in the postoperative pulmonary resection in treatment for pulmonary tuberculosis or fungal infection, tracheostomy or mechanical obstruction of the trachea. Patients with myopathy or neurological sequelae (stroke or encephalopathy) that prevent the implementation of the measures necessary for the study.
研究者
相似试验
进行中（未招募）
不适用
A comparative study of inhaled ciclesonide versus placebo in children with asthma (RAINBOW) - RAINBOWAsthma bronchialMedDRA version: 8.1Level: LLTClassification code 10003555Term: Asthma bronchialEUCTR2006-000803-40-DEycomed GmbH1,050
进行中（未招募）
1 期
A comparative study of inhaled ciclesonide versus placebo in children with asthma (RAINBOW)Estudio comparativo de ciclesonide inhalado frente a placebo en niños con asma - RAINBOWAsthma bronchialAsma bronquial persistenteMedDRA version: 9.0Level: LLTClassification code 10003555EUCTR2006-000803-40-ESALTANA Pharma AG1,080
进行中（未招募）
不适用
A comparative study of inhaled ciclesonide versus placebo in children with asthma (RAINBOW) - RAINBOWEUCTR2006-000803-40-HUALTANA Pharma AG1,050
进行中（未招募）
不适用
Comparison of inhaled ciclesonide (640 µg/day) and fluticasone propionate (1000 µg/day) in patients with moderate and severe per-sistent asthmaasthmaMedDRA version: 5.1Level: lltClassification code 10003553EUCTR2004-001681-40-GBALTANA Pharma AG515
进行中（未招募）
不适用
Comparison of inhaled ciclesonide (640 g/day) and fluticasone propionate (1000 g/day) in patients with moderate and severe persistent asthma.moderate and severe persistent asthmaMedDRA version: 6.1Level: PTClassification code 10003553EUCTR2004-001681-40-ITALTANA PHARMA